The fate of an experimental MAO inhibitor, N-cyclopropyl-2-chlorophenoxyethylamine (Lilly 51641) in the rat and in man.
D000588:Amines / Q000378:metabolism; D000818:Animals; D002250:Carbon Radioisotopes; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D003521:Cyclopropanes / Q000031:analogs & derivatives / Q000378:metabolism*; D003640:Dealkylation; D003641:Deamination; D005021:Ethylamines / Q000378:metabolism; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D008862:Microsomes, Liver / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism*; D010084:Oxidation-Reduction; D010642:Phenoxyacetates / Q000378:metabolism; D010647:Phenyl Ethers / Q000378:metabolism; D051381:Rats
D000588:Amines; D002250:Carbon Radioisotopes; D003521:Cyclopropanes; D005021:Ethylamines; D008996:Monoamine Oxidase Inhibitors; D010642:Phenoxyacetates; D010647:Phenyl Ethers